Clinical and morphological characteristics and prognosis of BRCA-associated breast cancer in women of the reproductive age
https://doi.org/10.17650/1994-4098-2012-0-1-20-23
Abstract
During last years one should note an unstoppable increase of the breast cancer incidence among patients of reproductive age. A group of pa- tients of young age with the breast cancer whose disease is associated with the BRCA1/2 genes is of particular scientific interest. However, until now no single opinion on survival results in the given group of oncological patients has been evolved yet. In this article, preliminary data on general and non-recurrence survival of patients of the reproductive age are given, depending on BRCA1 gene status.
About the Authors
D. E. Avtomonov
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. A. Parokonnaya
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L. N. Lyubchenko
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. I. Nechushkin
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
N. I. Pospekhova
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2004 г. Вестн РОНЦ им. Н.Н. Блохина РАМН 2006;17(3):132.
2. Innes K., Byers T., Schymura M. Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 2000;152(12):1121–8.
3. Kothari A.S., Fentiman I.S. Breast cancer in young women. Int J Clin Pract 2002;56(3):184–7.
4. Федорова О.Е., Любченко Л.Н., Паяниди Ю.Г. и др. Использование биочипов при изучении распространенных мутаций в генах BRCA 1/2 и CHEK 2 у больных органо- специфичным раком яичников и первично-множественными злокачественными новообразованиями с поражением яичников (российская популяция). Мол биол 2007;41(1):37–42.
5. Ford D., Easton D.F., Stratton M. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676–89.
6. Любченко Л.Н., Гарькавцева Р.Ф. ДНК-диагностика и медико-генетическое консультирование при наследственном раке молочной железы. В кн.: Рак молочной железы. Под ред. Н.Е. Кушлинского, С.М. Портного, К.П. Лактионова. М.: РАМН, 2005. С. 198–209.
7. McDonnell S., Schaid D., Myers J. et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 2001;19(19):3938–43.
8. Graeser M.K., Engel C. et al. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutants. J Clin Oncol 2009;27(35):25–30.
9. Поспехова Н.И., Логинова В.П., Шубин В.П. и др. Двухсторонний рак молочной железы в Российской популяции: молекулярно-генетические, семейные и клинические характеристики. Мол мед 2010;(3):38–42.
10. Brenner R.J., Bassett L.W., Fajardo L.L. et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology 2001;218:866–72.
11. Brinton L., Devesa S. Incidence, demographics, and enviromental factors. In: Diseases of the breast. Harris J., Morrow M., Lippman M. et al. eds. Philadelphia: Lippincott-Raven Publishers, 1996. P. 159–68.
12. Johannsson O., Ranstam J., Borg A. et al. Survival of BRCA1 breast and ovarian cancer in patients: a population-based study from southern Sweden. J Clin Oncol 1998;16(1):397–404.
13. Johannsson O., Borg A., Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carries. Lancet 1998;352:1359–60.
14. Verhoog L., Brekelmans C., Seynaeve C. et al. Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;35:316–21.
Review
For citations:
Avtomonov D.E., Parokonnaya A.A., Lyubchenko L.N., Nechushkin M.I., Pospekhova N.I. Clinical and morphological characteristics and prognosis of BRCA-associated breast cancer in women of the reproductive age. Tumors of female reproductive system. 2012;(1):20-23. (In Russ.) https://doi.org/10.17650/1994-4098-2012-0-1-20-23
Views:
620
Email this article 